Avandia Lawyers

Have questions about Avandia? Contact us.

What is Avandia?
Avandia is an oral diabetes medicine that help control blood sugar levels. Avandia is for people with type 2 diabetes who do not use daily insulin injections. This medication is not for treating type 1 diabetes. Avandia may also be used for purposes other than those listed in this medication guide.

What are the dangers and risks of Avandia?

AVANDIA USERS
Sanders Viener Grossman, LLP, a law firm dedicated to fighting for victims of pharmaceutical companies that sold defective drugs, announced that lawsuits will soon be commenced in Federal Courts in both New York and New Jersey. These lawsuits will be filed against GlaxoSmithKline, the British manufacturer of the diabetes drug Avandia. The lawsuits will seek compensation on behalf of the many seriously and devastatingly injured individuals who were prescribed this diabetes drug.

A recent study conducted at the Cleveland Clinic and published in the New England Journal of Medicine suggests that Avandia may increase the risk of heart attack by 43% and death by 64%.

The Sanders Firm, a leader in the field of pharmaceutical litigation, has a history of helping people consistently achieve considerable settlements and recoveries. The Sanders Firm currently represents victims of defective drugs and products including Vioxx, Bextra, Celebrex, Ortho Evra, Guidant pacemaker and defibrillator, Oxycontin, and the Kugel Mesh Patch.

If you or a loved one is an AVANDIA victim, call the Sanders Firm for a free consultation to discuss whether you are eligible to make a claim. You may also fill out our web contact form below.

Recent Avandia Updates

Doctors Claim Glaxo Dismissed Worries on Avandia

Drug Maker Tried to Make Physician at Maryland Hospital Stop Talking About Concerns; Company Defends Its Effort

11.19.08 | The Wall Street Jounrnal
A ruckus erupted last year when reports surfaced that Glaxo was accused of intimidating John Buse, a University of North Carolina researcher who, years earlier, questioned the safety of its Avandia diabetes pill, which was linked to heart problems. However, he wasn’t the only one the drugmaker tried to stifle. Read Full Article Here.

Public Citizen Petitions FDA to Ban Diabetes Drug Avandia, According to Avandia Plaintiffs Attorney Group

11.6.08 | LexisNexis Press Release
National non-profit organization documents upsurge in negative clinical data associated with use of Avandia, urges FDA commissioner to remove drug from U.S. market immediately Thus, it is urgent for the FDA to immediately ban rosiglitazone (Avandia). Read Full Article Here.

Diabetes Drug Makes Body Reabsorb Bone, Making Bones Weaker

12.3.07 | Medical News Today
Avandia, a drug for treating diabetes type 2, encourages the body to reabsorb bone, making them weaker and more likely to break, say experts. Avandia, a top selling drug, is made and marketed by GSK (GlaxoSmithKline).

Studies had previously indicated that Avandia raised the risk of developing bone fractures among women. A new report, published in Nature , confirms this, it also explains why this is so. The drug, say scientists, boosts the action of osteoclasts, cells that weaken bones.

According to team leader, Professor Ronald Evans, the Salk Institute for Biological Studies , La Jolla, California, there is a delicate balance between the deposition of new bone and the removal of old bone. Every bit of bone that is taken away should be counteracted by the same amount of new bone added, he explained. With Avandia, however, cells that take bone away are stimulated, while cells that create bone are calmed down - the result being that the body destroys bone faster than it is replenishing it.

Evans stressed that patients should not immediately go off Avandia. There are drugs that can make up for this bone loss. Rather, he says, patients should be carefully monitored.

Avandia has also been associated with raised heart attack risk. The drug will carry a black box warning about heart attacks and chest pains in the USA.